// company-profile
Crinetics Pharmaceuticals, Inc. Insider Trading
CRNXEvery SEC Form 4 insider trading filing for Crinetics Pharmaceuticals, Inc. (CRNX) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=CRNX" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Crinetics Pharmaceuticals, Inc. insiders bought $0 across 14 transactions with no open-market sales.
- Most active insider: Struthers Richard Scott with 14 transactions totaling $0.
- Largest single sale: $224K by Okey Stephanie on Jun 17, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Crinetics Pharmaceuticals, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Vivaldi Coelho Rogerio | CRNX | Sale10b5 | 3,000 | $40.00 | $120K |
| Jun 18, 2026 | Bedrosian Camille L | CRNX | Award | 9,730 | $0.00 | $0K |
| Jun 18, 2026 | Deardorf Caren | CRNX | Award | 5,925 | $0.00 | $0K |
| Jun 18, 2026 | Vivaldi Coelho Rogerio | CRNX | Award | 5,925 | $0.00 | $0K |
| Jun 18, 2026 | Vivaldi Coelho Rogerio | CRNX | Award | 9,730 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →